OFFICIAL-SOURCE RECALL · UNITED KINGDOM
Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi Recall: to product quality as a result of this
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe, EL(26)A/27
- Manufacturer
- See official notice
- GTIN
- 05017007608233
- EAN
- 5017007608233
- Lot number
- batch-numbers, Batch
- Batch number
- numbers, Numbers
- Date code
- Date
- Expiration date
- Date
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
to product quality as a result of this labelling error. Aside from the labelling error, no additional errors have been identified with the product or delivery device, therefore the affected batches are not being recalled. Healthcare professionals are advised to reassure patients, if
Hazard
to product quality as a result of this labelling error. Aside from the labelling error, no additional errors have been identified with the product or delivery device, therefore the affected batches are not being recalled. Healthcare professionals are advised to reassure patients, if
Official recall notice
Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe, EL(26)A/27
Agency: Medicines and Healthcare products Regulatory Agency
Official publication date: June 4, 2026
Read the official UK_MHRA recall notice →Scan products you own
Scan products you own once and let RecallGuard monitor future official recalls.
Scan & Monitor Products